MEDTRONIC PUERTO RICO OPERATIONS CO. INTERSTIM II; STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCONTINENCE
|
Back to Search Results |
|
Model Number 3058 |
Device Problems
Break (1069); Energy Output Problem (1431); Human-Device Interface Problem (2949)
|
Patient Problem
Therapeutic Effects, Unexpected (2099)
|
Event Date 11/25/2019 |
Event Type
Injury
|
Manufacturer Narrative
|
Concomitant medical products: product id: 3889-28, lot#: 0218222950, implanted: (b)(6) 2019, explanted: (b)(6) 2019, product type: lead.Product id: 3889-28, serial/lot #: (b)(4), ubd: 30-jul-2023, udi#: (b)(4).If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Information received from the healthcare professional (hcp) via manufacturer representative (rep) reported a broken tined lead in the implantable neurostimulator (ins).It was reported that the tined lead was broken inside the ins and was not fixed by the screw.The tip of the lead was still in the ins.Factors that may have led or contributed to the issue was that the patient slid down a stair.Then they reported another stimulation feeling, mostly into their left leg.After a control, they saw that the lead were no longer at the place like it was before (x-ray control).The impedance was okay.No failure was seen there so it was decided to replace the lead.Troubleshooting performed included x-ray and impedance control.Actions taken included a complete change of the whole system.The issue was resolved and a surgical intervention occurred.
|
|
Manufacturer Narrative
|
Product id: 3889-28, lot# 0218222950, implanted: (b)(6) 2019, explanted: (b)(6) 2019, product type: lead.Analysis of the ins (s/n: (b)(4)) found the set screw was backed out too far.Analysis of the lead (s/n: (b)(4)) found the proximal end of the lead was stretched.(b))(4).If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Continuation of d11: product id 3889-28 lot# 0218222950 serial# implanted: (b)(6) explanted: (b)(6) product type lead medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Concomitant medical product: product id 3889-28 lot# 0218222950 serial# implanted: (b)(6) 2019 explanted: (b)(6) 2019 product type lead correction to g5: corrected/changed back to p970004.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|